全文获取类型
收费全文 | 32130篇 |
免费 | 2987篇 |
国内免费 | 1469篇 |
专业分类
耳鼻咽喉 | 286篇 |
儿科学 | 407篇 |
妇产科学 | 560篇 |
基础医学 | 6767篇 |
口腔科学 | 610篇 |
临床医学 | 1700篇 |
内科学 | 3925篇 |
皮肤病学 | 717篇 |
神经病学 | 1655篇 |
特种医学 | 530篇 |
外国民族医学 | 15篇 |
外科学 | 2565篇 |
综合类 | 4300篇 |
现状与发展 | 6篇 |
预防医学 | 956篇 |
眼科学 | 296篇 |
药学 | 3330篇 |
2篇 | |
中国医学 | 722篇 |
肿瘤学 | 7237篇 |
出版年
2024年 | 54篇 |
2023年 | 483篇 |
2022年 | 674篇 |
2021年 | 1230篇 |
2020年 | 970篇 |
2019年 | 1056篇 |
2018年 | 913篇 |
2017年 | 877篇 |
2016年 | 819篇 |
2015年 | 1140篇 |
2014年 | 1638篇 |
2013年 | 1658篇 |
2012年 | 1466篇 |
2011年 | 1857篇 |
2010年 | 1715篇 |
2009年 | 1725篇 |
2008年 | 1757篇 |
2007年 | 1809篇 |
2006年 | 1637篇 |
2005年 | 1560篇 |
2004年 | 1488篇 |
2003年 | 1411篇 |
2002年 | 1212篇 |
2001年 | 1098篇 |
2000年 | 990篇 |
1999年 | 813篇 |
1998年 | 717篇 |
1997年 | 623篇 |
1996年 | 519篇 |
1995年 | 412篇 |
1994年 | 281篇 |
1993年 | 211篇 |
1992年 | 155篇 |
1991年 | 124篇 |
1990年 | 85篇 |
1989年 | 87篇 |
1988年 | 106篇 |
1987年 | 75篇 |
1986年 | 91篇 |
1985年 | 158篇 |
1984年 | 174篇 |
1983年 | 90篇 |
1982年 | 110篇 |
1981年 | 87篇 |
1980年 | 84篇 |
1979年 | 64篇 |
1978年 | 58篇 |
1977年 | 55篇 |
1976年 | 43篇 |
1975年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 265 毫秒
41.
人原发性肝癌中p16基因表达及CpG岛甲基化状态的研究 总被引:1,自引:0,他引:1
目的 进一步探讨人原发性肝癌中 p16基因 m RNA转录水平变化与其基因启动子区 Cp G岛甲基化的关系 ,及其在肝癌发生中的意义。方法 采用狭缝印迹杂交检测 2 0例人原发性肝癌及相应的癌旁、远癌组织及 2例正常人肝组织中 p16基因 m RNA表达水平 ,以甲基化特异性 PCR分析各组织中 p16基因启动子区 Cp G岛的甲基化状况 ,并进行统计分析。结果 2 0例人原发性肝癌中 14例 (70 % ) p16 m RNA水平比远癌组织显著降低 ;13例 (6 5 % )显示 p16基因启动子区 Cp G岛甲基化 ,其中 84 .6 % (11例 )伴 p16 m RNA转录水平降低。结论 人原发性肝癌中存在高频率的 p16基因表达失活 ,其主要机制可能是启动子区 Cp G岛甲基化抑制了基因的转录 ,在人原发性肝癌的发生发展中有重要作用。其临床诊断和治疗意义有待进一步深入研究。 相似文献
42.
p14ARF基因和核转录因子E2F-1在细胞周期调控,细胞凋亡和肿瘤发生中具有重要作用。近年来,有研究表明p14ARF在肺癌中的表达率低于正常组织,E2F-1的表达率高于正常组织。本文将就p14ARF、E2F-1与肺癌的关系进行综述。 相似文献
43.
Objective To test the hypothesis that p53 gene therapy combined with endostatin can enhance tumor response to radiation therapy of RM-1 mouse xenograft prostate cancer and to investigate its mechanism. Methods A mouse prostate cancer model was established. Then mice with xenograft tumor were randomly divided into group A (control), B (radiation), C (radiation and rAdp53), D (radiation and rh-endostatin) and E (radiation and rAdp53 and rh-endostatin). On day 1, rAdp53 was injected intra-tumorously with 1 × 1010 vp per animal to group C and E. From day 1 to 14, rh-endostatin was given 15 mg/kg intraperitoneally daily to group D and E. On day 4 single fraction of 15 Gy was given to tumors in groups B, C, D and E. Normal saline was injected intra-tumorously or intraperitoneaUy accordingly as control. No treatment was done to group A. Tumor volume was measured daily. Samples were collected on Days 5, 10 and 15. Ki67, CD31, p53 and VEGF were detected by means of immunohistochemistry. Results (1) Radiation alone, radiation combined with intra-tumorous injection of Adp53 and/or intraperitoneal injection of rh-endostatin resulted in tumor growth arrest of RM-1 cells in vivo (P = 0.000). Radiation combined with both rAdp53 and rh-endostatin was the most effective treatment (P < 0.05). (2) All the four treatment groups had a decreased expression of mutant type P53 (P = 0.000). The expression of Ki67 in groups B and C were equal (P 0.05) and increasing (P = 0.000), respectively. Group D had a up-down-up curve (P < 0.05), but group E had a up-down one. On day 5 the expresion of VEGF in group E was the lowest (P < 0.05). An increased expression of MVD compared with the control was shown, and MVD in groups C, D and E were always higher than that in the control (P < 0.05). Conclusions The limitation of radiotherapy could be overcome by combination with beth p53 gene therapy and endostatin on the growth of mouse prostate cancer cell. Radiation, rAdp53 and endostatin have their own role but they can be interacted with each other. 相似文献
44.
We performed an open, double-blind, and long-term study of vigabatrin (gamma-vinyl-GABA, GVG) in patients with treatment-resistant epilepsy who were receiving only one or at most two standard antiepileptic drugs (AEDs). The novel design included a parallel, double-blind, placebo-controlled phase that minimized the number of patients receiving placebo and allowed determination of the optimum dose of GVG for each patient before initiation of the double-blind phase. The study was divided into four phases. The first phase was a 6-week period of baseline observation. In the second phase, GVG was added openly to previous AEDs for 8 weeks. During the first 2 weeks of this phase, the dose of GVG was increased weekly and then, in the absence of adverse effects, was held constant for the next 6 weeks. At the end of this open phase, seizure frequency during the 6 weeks of constant treatment was compared with the baseline seizure frequency for each patient. Patients who experienced reduction greater than 50% in the frequency of any seizure type during the open phase were defined as responders. These responders were then entered into the third and double-blind phase, in which they were randomly allocated wither to continue active GVG treatment or placebo for 8 weeks. Thirty-three patients entered the study; 31 of 33 patients completed the initial open phase. Twenty patients achieved a reduction greater than or equal to 50% in the frequency of one or more seizure types and were eligible for the double-blind phase; 10 were randomized to continue GVG and 10 were randomized to placebo.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
45.
L. van den Bemt M. P. de Vries L. van Knapen M. Jansen M. Goossens J. W. M. Muris C. P. van Schayck 《Clinical and experimental allergy》2006,36(2):233-237
BACKGROUND: Exposure to a high level of house dust mite allergens (HDMAs) is considered as a risk factor for HDM sensitization and development of asthma in genetically disposed people. Mattresses are one of the most important sources of HDMA in people's living environment. OBJECTIVE: The aim of this study was to evaluate the association between mattress characteristics and HDMA concentrations on mattresses. METHODS: Dust samples of mattress surfaces were taken to evaluate the level of Der p 1 allergen. All participants filled in a questionnaire about the type of mattress, the type of covering (upper layer) of the mattress, dwelling characteristics and cleaning habits. Humidity and temperature of the bedroom were measured at the time of dust sampling. RESULTS: One hundred and sixty-eight questionnaires were filled in. Synthetic upper layer of the mattress was associated with a higher level of Der p 1 compared with cotton upper layer (2.6 vs. 0.8 microg/g Der p 1). Moreover, higher relative humidity (RH) was associated with significant higher concentrations and density of Der p 1. CONCLUSIONS: Two factors were associated with lower levels of Der p 1 found on mattresses, namely: a cotton upper layer of the mattress compared with a layer of synthetic material and lower RH at the time of sampling. As far as we know, the association between type of upper layer and concentration of Der p 1 has not been described before and could lead to the formulation of practical advices in order to reduce HDMA concentrations on mattresses. 相似文献
46.
Expression of Anion Exchanger 1 Sequestrates p16 in the Cytoplasm in Gastric and Colonic Adenocarcinoma 下载免费PDF全文
Wei-Wei Shen Jun Wu Li Cai Bing-Ya Liu Yan Gao Guo-Qiang Chen Guo-Hui Fu 《Neoplasia (New York, N.Y.)》2007,9(10):812-819
p16INK4A (p16) binds to cyclin-dependent kinase 4/6 and negatively regulates cell growth. Recent studies have led to an understanding of additional biologic functions for p16; however, the detailed mechanisms involved are still elusive. In this article, we show an unexpected expression of anion exchanger 1 (AE1) in the cytoplasm in poorly and moderately differentiated gastric and colonic adenocarcinoma cells and in its interaction with p16, thereby sequestrating the protein in the cytoplasm. Genetic alterations of p16 and AE1 were not detectable. Forced expression of AE1 in these cells sequestrated more p16 in the cytoplasm, whereas small interfering RNA-mediated silencing of AE1 in the cells induced the release of p16 from the cytoplasm to the nucleus, leading to cell death and growth inhibition of tumor cells. By analyzing tissue samples obtained from patients with gastric and colonic cancers, we found that 83.33% of gastric cancers and 56.52% of colonic cancers coexpressed AE1 and p16 in the cytoplasm. We conclude that AE1 plays a crucial role in the pathogenesis of gastric and colonic adenocarcinoma and that p16 dysfunction is a novel pathway of carcinogenesis. 相似文献
47.
p53,p16,PCNA蛋白在食管癌中的表达及其临床意义 总被引:3,自引:0,他引:3
目的探讨p53,p16,PCNA蛋白在食管癌中的表达及临床意义。方法用免疫组织化学染色SP法对62例食管癌标本进行p53,p16,PCNA蛋白测定。结果62例食管癌中,p53,PCNA蛋白阳性表达均为71.0%(44/62),p16缺失率48.4%(30/62)。p16缺失与肿瘤浸润深度、淋巴结转移密切相关(P<0.05、P<0.01)。而p53,PCNA蛋白同时表达56.5%(35/62),亦与肿瘤浸润深度、淋巴结转移密切相关(P<0.05、P<0.01)。结论食管癌p53,PCNA蛋白同时表达及p16缺失可视为危险预后因素。 相似文献
48.
p63基因在小细胞肺癌及肺腺癌组织中转录表达水平的研究 总被引:2,自引:0,他引:2
49.
白细胞介素-15对骨髓增生异常综合征骨髓造血干/祖细胞增殖的影响 总被引:1,自引:0,他引:1
目的:观察白细胞介素(IL-15)对体外培养的骨髓增生异常综合征(MDS)患者CD34^ 细胞增殖作用。方法:应用单克隆抗体免疫磁珠分离系统提取MDS患者CD34^ 细胞,以加IL-15组为实验组,不加IL-15组为对照组,进行液体和甲基纤维素半固体集落培养,计算培养后细胞数和CFU—E、BFU—E、CFU—GM、CFU—GEMM等集落数,并用MTT比色法检测IL-15对MDS患者CD34^ 细胞增殖的抑制作用,流式细胞术检测上述培养细胞周期的变异情况。结果:11例MDS对象平均CD34^ 细胞比例、回收率、纯度和富集倍数均达要求,MTT比色法检测IL-15对CD34^ 细胞的增殖作用呈最佳浓度效应,最佳浓度为20μg/L,细胞增殖抑制最低峰值时间为8d。用0μg/L IL-15(对照组)和20μg/L IL-15(实验组)作用MDS CD34^ 细胞,计数显示培养细胞最大增殖倍数和集落形成比率实验组均较对照组明显增加,IL-15作用后各细胞周期G1、S、G2期比例有明显改变,与对照组比较,差异有统计学意义。结论:IL-15对MDS CD34^ 细胞有促增殖效应,与其它造血生长因子具有协同作用,对MDS治疗可能有一定的应用前景。 相似文献
50.
目的 观察外源性P53蛋白对不同传能线密度(LET)射线辐照诱导肿瘤细胞凋亡和坏死的影响,并探讨其可能的机制。方法 人黑色素瘤细胞系A375(wild-type p53)经携带人野生型p53基因的腺病毒载体(AdCMV-p53)感染后分别给予X射线和碳离子束照射,采用克隆形成法测定细胞辐射敏感性,Hoechst 33258和吖啶橙-溴化乙锭双染荧光显微镜下观察细胞凋亡和坏死。结果1高LET辐照时,A375细胞和转导人野生型p53基因的A375细胞(A375/p53)的辐射敏感性没有明显差异;2虽然辐射诱导细胞凋亡比例的增加依赖于LET升高,但是无论高LET或低LET,外源性P53蛋白均可有效诱导细胞凋亡。3高LET辐照时,A375细胞的坏死细胞明显高于A375/p53细胞。结论 尽管高LET辐射对A375和A375/p53细胞的存活无明显影响,但是对细胞凋亡的诱导却部分依赖于P53蛋白的功能,P53蛋白可能在调节细胞死亡类型中发挥重要作用。这对临床应用高LET辐射联合p53基因治疗恶性黑色素瘤有一定参考意义。 相似文献